Ethanolic and aqueous extracts of the natural compound PROPOLIS indicate substanti al antiinflammatory functions as well as antibiotic activities in vitro and in vivo. The exact mode of physiological or biochemical mechanisms responsible for the medical effects, ho wever, is all but clear. The standardization on the basis of quantitative determination of pro minent components of these extracts have been substituted recently by simple biochemical model reactions including photodynamic properties. In this communication we report on the inhibitory activity of an aqueous extract of propolis on the enzyme dihydrofolate reductase. This activity may at least partially be due to the content of caffeic acid, as revealed by HPLC chromatography and comparative activity tests of representative ingredients of the propolis extract. This result may explain some of the protective functions of propolis, similar to those shown for several "non-steroidal antiinflammatory drugs", NSAIDs.
Introductio n H oney bees collect a resinous substance from the buds of different trees. They convert it to the bee glue, called "Propolis", and use it to seal th eir hive. Propolis extracts have widely been used in folk m edicine for the treatm en t of infections of the skin, m ucosa and m outh. Propolis contains num erous ali phatic and arom atic com pounds such as terpenes, phenylpropane derivatives, flavonoids, am ino acids and different aldehydes and ketones, alto g eth er m ore than 150 substances [1 -6 ] .
T he antibacterial and antifungal activities and thus antiseptic properties [7 -1 3 ] especially w ar ran ted the use of these extracts in m edicine [14, 15] . Im m une m odulatory activities o f aqueous extracts from propolis seem to be responsible for th e in creased protection against gram negative infections via m acrophage activation [16, 17] . T hese p ro p erties as well as antiinflam m atory and antiphlogis tic effects m ay be due to several com ponents of these extracts of propolis which m ay m ed iate th eir beneficial m edical effects through the antioxidant properties rep o rted in the preceding com m unica tions [18, 19] .
Abbreviations: NSAIDs, non-steroidal antiinflamma tory drugs; DHFR, dihydrofolate reductase; DHF, dihyarofolate; WSD, aqueous extract of propolis. Reprint requests to Prof. Dr. Elstner. Verlag der Zeitschrift für Naturforschung, D-72072 Tübingen 0939-5075/94/0100-0039 $01.30/0 D ihydrofolate reductase (D H F R ) plays an im p o rta n t role in interm ediary m etabolism especially in rapidly dividing cells such as bacterial cultures or uncontrolled grow ing tissues like tum ors. This enzym e transfers H + to N-5 of dihydrofolate (D H F). As a consequence, the more electrophilic D H F gets a hydrid ion from th e ternary D H F R -N A D P H -D H F com plex and reg en erates tetrahydrofolate (TH F). This m olecule, in tu rn , transfers activated C -l units necessary for th e biosynthesis of purines, pyrim i dines and certain essential am ino acids such as m e thionine. It is conceivable th at inhibition of this enzym e provokes cytostatic and antibacterial ef fects [20, 21] .
M eth o trex ate (4-am ino-10-m ethylfolic acid) is a chem ical analogon of D H F and a well know n in hibitor of D H F R . T hereby, the pteridine ringsystem of m eth o trex ate binds to the active centre of the enzym e, which is su rrounded by a hydrophobic p ro tein m oiety. T he N -l of the coenzym e form s a hy drogen bridge w ith the pro to n ated Glu-30 in the active site of the enzym e [22] .
M ethylbenzoprim is an o th er strong inhibitor of this enzym e. This substance also form s hydrogen bonds betw een its diam ino pyrim idine ringsystem and th e am ino acids Glu-30, Thr-136, Ile-7 and Val-112 in the active centre of the enzyme. Both arom atic rings of m ethylbenzoprim fit into the hy drophobic pocket of D H F R [23] .
B aggott et al. [21] show ed th a t several non-ste roidal antiinflam m atory drugs (N SA ID s) inhibited D H F R . This fact m ay thus explain p a rt o f th eir an ti inflam m atory effect. In this com m unication we re p o rt on significant inhibition of D H F R activity by an aqueous extract of propolis. H PL C -chrom atographic separation of this extract and subsequent activity tests show ed th at caffeic acid was the m ost active com ponent with an I50-value o f approxi m ately 80 |iM. Cinnam ic acid, vanillin and ferulic acid show ed only negligible activities. T h e aro m a tic am ino acid dihydroxyphenylalanine (D O P A ) is a structurally related com pound to caffeic acid. D O P A exhibits approxim ately 40% activity as com p ared to caffeic acid. This effect and th e lack of activity of cinnam ic acid allows the conclusion th at an o-dihydroxy configuration in addition to the double b ond in the C-3 side chain m ay re p re se n t the im p o rtan t structural features for th e inhibitory ef fect of these phenylpropane (C 6-C 3) derivatives. This reaction m ixture was preincubated for 5 min at 37 °C and started with 100 ptl D H F (600 jxm). In cubation tim e was 4 h at 37 °C in the dark. O ne unit will convert 1.0 [imole of 7.8-dihydrofolate and N A D P H to 5.6.7.8-tetrahydrofolate and N A D P + p er m in at p H 6.5 at 25 °C.
M aterials and M ethods
c) E nzym e activity was determ ined according to B ratton-M arshall [24] A fter incubation tim e, the reaction was stopped by the addition of 0.6 ml sulfuric acid (5 m ) and 1.1 ml N aC l (0.3 m ).
T hen, the test solutions w ere transfered to an ice b ath and the following reagents w ere added: 0.2 ml sodium nitrite (0.1% ), 0.2 ml am m onium sulfamate (0.5% ), 0.2 ml a-naphthylethylene diam ine (0.1% ).
T h e reaction m ixture was incubated for 75 m in at room tem p eratu re in th e dark in o rd er to develop th e red azo-dye w ith an absorption m axim um at 540 nm . T he extinctions in the absence of an in h ib ito r w ere set as 100% activity. A ll reactions w ere carried o ut with five parallels and m ean values with stan d a rd deviations w ere calculated for th e tables an d figures.
R esults an d D iscussion

Inhibition o f dihydrofolate reductase by untreated aqueous extract o f propolis (W SD )
T he D H F R reaction is inhibited by increasing am ounts of added W SD (Fig. 1) . A 50% reduction o f activity is obtained by ca. 1.2 vol.% of the extract. 
Extraction o f the untreated aqueous extract o f propolis with petrol ether
E x tractio n of th e W SD with petrol eth e r yields two new aqueous p reparations, nam ly the aqueous phase derivative and th e lipophilic phase derivative (see M aterials, a). T he absorption spectrum b e tw een 200 nm and 800 nm of th e aqueous p etro l eth er su p e rn a ta n t shows no change as com pared to u n tre a te d W SD (Fig. 2 a) . B oth extracts exhibit high absorption in th e U V with a small peak at 295 nm and a strong decrease betw een 300 and 350 nm . N early no absorption was m easured at higher w avelengths. 100% of the activity is left in this new extracted aqueous phase, w hereas th e re dissolved, lipophilic petrol eth e r phase has no effect on D H F R activity (d ata not shown).
Charcoal treatment o f the aqueous extract o f propolis
T he filtrate after charcoal treatm en t exhibits an absorption spectrum strongly different from the u n tre a te d W SD. T he spectrum shows a considerable loss of ab so rp tio n b etw een 210 nm and 290 nm and a distinct an d b ro ad absorption m axim um around 295 nm. T he loss of absorption at 250 nm is ap proxim ately 70% . D espite this altered spectrum , th e charcoal filtrate contains the sam e inhibitory activity com pared to th e u n trea ted W SD. In con trast, the E tO H -am m o n ia -trea ted aqueous char coal wash is inactive (Fig. 2 b) .
Separation o f different preparations o f propolis by H P L C
T he elution profile of u n tre a te d W SD was not sig nificantly changed in the filtrate after charcoal treatm en t. T he m olarities of caffeic acid, vanillin, ferulic acid and cinnam ic acid in the extracts (see M aterials, b) before and after charcoal treatm en t are com pared in T able I. Table I . Concentrations of aromatic compounds in aqueous extracts of propolis before and after charcoal treatment. T he com parison of the concentrations of differ ent identified com pounds w ith the corresponding activities before and after charcoal treatm en t clear ly indicates th a t caffeic acid only suffers from an approxim ately 20% loss by the treatm ent, while vanillin is red u ced by ca. 70% , ferulic acid by rough ly 60% and cinnam ic acid by 65% . In o rder to test w hether these com pounds contribute to the inhibi tion of D H F R we tested th e authentic chemicals in the D H F R assay.
A s show n in Fig. 3 only caffeic acid is significant ly inhibiting D H F R activity. A n I50-value of 80 can be calculated. Since none of the above com pounds besides caffeic acid has an unsub stitu ted o-3.4-dihydroxy arom atic m oiety we com pared D O P A (o-3.4-dihydroxy phenylalanin) on its influence on D H F R ac tivity. In com parison to caffeic acid, D O P A shows reduced inhibitory activity exhibiting an I50-value at approxim ately 200 (Fig. 4) . Thus, th e u n saturated side chain itself as the su b stitu en t of an arom atic body (ferulic acid, cinnam ic acid) is not essential for D H F R inhibition. T he o-dihydroxy configuration in the absence of the u nsaturated C-3 side chain (D O P A ) shows reduced activity as com pared to caf feic acid configuration. This fact renders the o-3.4-dihydroxy-l-propene carboxylate m oiety as the im p o rta n t structural feature for m axim al inhibitory ac tivity. 
Conclusion
From the presented results we conclude th at W SD of propolis may exert som e of its antiinflam m atory and antiinfectuous properties via the inhi bition of D H F R activity sim ilar to the rep o rt on well know n N SA ID s [21] . This enzym e plays an im por ta n t role in interm ediary C -l m etabolism and is one basic enzymic requirem ent in fast growing and/or dividing cells (bacteria) and tissues (tum ours). This p roperty is in p art due to caffeic acid as one of at least 16 m ajor (arom atic or heterocyclic) com po nents of W SD of propolis, detectable after H PL C separation at 280 nm.
